| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.48 | 0.007 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-10 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |